← The SEC Ephemeris: the whole map
Acacia Pharma Ltd Barhemsys
In the graph: all 2 documents (5 pages).
- Application
- NDA 209510
- Ticker
- Acacia Pharma Ltd
- Product
- Barhemsys
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- May 2, 2019 · October 5, 2018
From FDA letters and SEC filings. Not investment or medical advice.